tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $3.64. This is a potential upside of $3.64 (0%) from yesterday's end of day stock price of $0.
Jounce Therapeutics's activity chart (see below) currently has 44 price targets and 35 ratings on display.
Analysts average stock forecasts to be materialized ratio is 30.56% with an average time for these price targets to be met of 292.44 days.
Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 27-Mar-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$0.12 (6.38%)
$7
2 years 7 months 2 days ago
(27-Mar-2023)
0/4 (0%)
$0.16 (8.70%)
Hold
$3
2 years 8 months 7 days ago
(22-Feb-2023)
2/8 (25%)
$1.83 (156.41%)
622
Buy
$5
$3.12 (165.96%)
$9
2 years 9 months 27 days ago
(02-Jan-2023)
0/3 (0%)
$3.91 (358.72%)
Buy
$11
$9.12 (485.11%)
$15
3 years 2 months 25 days ago
(04-Aug-2022)
0/2 (0%)
$6.84 (164.42%)
Buy
$15
$13.12 (697.87%)
$15
3 years 5 months 18 days ago
(11-May-2022)
0/4 (0%)
$10.75 (252.94%)
What is JNCE (Jounce Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the current lower performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?
Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?
Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?
